X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (105) 105
index medicus (99) 99
hematology (75) 75
middle aged (73) 73
female (69) 69
male (69) 69
prognosis (61) 61
aged (60) 60
adult (55) 55
oncology (54) 54
rituximab (49) 49
antineoplastic combined chemotherapy protocols - therapeutic use (48) 48
treatment outcome (44) 44
lymphoma, large b-cell, diffuse - drug therapy (42) 42
aged, 80 and over (39) 39
chemotherapy (34) 34
elderly-patients (33) 33
lymphomas (33) 33
non-hodgkins-lymphoma (33) 33
lymphoma, large b-cell, diffuse - pathology (29) 29
survival (29) 29
adolescent (28) 28
abridged index medicus (27) 27
cyclophosphamide - administration & dosage (27) 27
vincristine - administration & dosage (27) 27
cancer (26) 26
lymphoma (26) 26
doxorubicin - administration & dosage (25) 25
lymphoma, large b-cell, diffuse - mortality (25) 25
b-cell lymphoma (24) 24
prednisone - administration & dosage (23) 23
retrospective studies (23) 23
young adult (23) 23
survival analysis (22) 22
disease-free survival (20) 20
cyclophosphamide (19) 19
follow-up studies (19) 19
survival rate (19) 19
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
neoplasm staging (17) 17
cyclophosphamide - therapeutic use (16) 16
doxorubicin - therapeutic use (16) 16
antibodies, monoclonal, murine-derived (15) 15
prednisone - therapeutic use (15) 15
risk factors (15) 15
therapy (15) 15
vincristine - therapeutic use (15) 15
analysis (14) 14
antibodies, monoclonal, murine-derived - administration & dosage (14) 14
doxorubicin (14) 14
expression (14) 14
vincristine (14) 14
care and treatment (13) 13
follicular lymphoma (13) 13
hemic and lymphatic diseases (13) 13
lymphoma, large b-cell, diffuse - diagnosis (13) 13
lymphoma, large b-cell, diffuse - genetics (13) 13
antibodies, monoclonal - administration & dosage (12) 12
antibodies, monoclonal, murine-derived - therapeutic use (12) 12
diffuse large b-cell lymphoma (12) 12
lymphoma, follicular - pathology (12) 12
risk (12) 12
rituximab - administration & dosage (12) 12
trial (12) 12
disease (11) 11
immune system diseases (11) 11
lymphoma, follicular - drug therapy (11) 11
lymphoma, follicular - genetics (11) 11
r-chop (11) 11
time factors (11) 11
chronic lymphocytic-leukemia (10) 10
disease progression (10) 10
dlbcl (10) 10
immunohistochemistry (10) 10
lymphoma, large b-cell, diffuse - metabolism (10) 10
multivariate analysis (10) 10
phase-ii (10) 10
prednisone (10) 10
british columbia - epidemiology (9) 9
central nervous system (9) 9
chop (9) 9
clinical trials as topic (9) 9
gene expression profiling (9) 9
hematology, oncology and palliative medicine (9) 9
lymphocytes b (9) 9
non-hodgkin-lymphoma (9) 9
randomized controlled-trial (9) 9
recurrence (9) 9
rituximab plus cyclophosphamide (9) 9
antineoplastic agents - therapeutic use (8) 8
chemotherapy plus rituximab (8) 8
cohort studies (8) 8
gene-expression (8) 8
lymphoid neoplasia (8) 8
proto-oncogene proteins c-bcl-2 - genetics (8) 8
tissue array analysis (8) 8
anti-cd20 monoclonal-antibody (7) 7
antibodies, monoclonal, humanized - administration & dosage (7) 7
antineoplastic combined chemotherapy protocols (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Best Practice and Research: Clinical Haematology, ISSN 1521-6926, 09/2018, Volume 31, Issue 3, pp. 185 - 186
Journal Article
Best Practice & Research Clinical Haematology, ISSN 1521-6926, 09/2018, Volume 31, Issue 3, pp. 185 - 186
Journal Article
Best Practice & Research Clinical Haematology, ISSN 1521-6926, 09/2018, Volume 31, Issue 3, pp. 185 - 186
Journal Article
Blood, ISSN 0006-4971, 04/2018, Volume 131, Issue 15, pp. 1629 - 1630
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2018, Volume 182, Issue 1, pp. 29 - 45
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 08/2018, Volume 59, Issue 8, pp. 1767 - 1768
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2014, Volume 167, Issue 5, pp. 608 - 617
Summary Diffuse large B‐cell lymphoma (DLBCL) is a heterogeneous disease with variable therapeutic responses and alternative therapies are needed for patients... 
rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone therapy | CD30 | immunohistochemistry | diffuse large B‐cell lymphoma | Epstein‐Barr virus | Immunohistochemistry | Rituximab plus cyclophosphamide | Epstein-Barr virus | Prednisone therapy | Doxorubicin | Vincristine | Diffuse large B-cell lymphoma | SURVIVAL | vincristine | and prednisone therapy | HODGKIN | rituximab plus cyclophosphamide | diffuse large B-cell lymphoma | doxorubicin | HEMATOLOGY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Gene Expression Regulation, Neoplastic | Male | Gene Expression Profiling | Lymphoma, Large B-Cell, Diffuse - metabolism | Aged, 80 and over | Vincristine - administration & dosage | Adult | Retrospective Studies | British Columbia - epidemiology | Doxorubicin - administration & dosage | Ki-1 Antigen - biosynthesis | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Neoplasm Proteins - biosynthesis | Survival Rate | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Adolescent | Aged | Lymphomas | Corticosteroids
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 344 - 344
Abstract Introduction MYC-rearrangement (MYC-R) occurs in approximately 10-15% of diffuse large B-cell lymphomas (DLBCL) and several studies suggest an... 
Journal Article
Blood, ISSN 0006-4971, 03/2017, Volume 129, Issue 9, pp. 1059 - 1060
Journal Article
Best Practice & Research Clinical Haematology, ISSN 1521-6926, 09/2018, Volume 31, Issue 3, pp. 209 - 216
Diffuse large B cell lymphoma represents the most common type of non-Hodgkin lymphoma. Although the curability rate is high, around 40% of patients will... 
Refractory | Diffuse large B cell lymphoma | Relapse | Treatment | AUTOLOGOUS TRANSPLANTATION | PHASE-II | RANDOMIZED-TRIAL | REDUCED-INTENSITY | ALLOGENEIC TRANSPLANTATION | B-CELL LYMPHOMA | NON-HODGKIN-LYMPHOMA | SALVAGE-CHEMOTHERAPY | HEMATOLOGY | HIGH-DOSE RITUXIMAB | ELDERLY-PATIENTS | Lymphomas
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 12/2016, Volume 30, Issue 6, pp. xiii - xiv
Journal Article
Best practice & research. Clinical haematology, 09/2018, Volume 31, Issue 3, p. 185
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 12/2016, Volume 2016, Issue 1, pp. 284 - 292
Journal Article
Haematologica, ISSN 0390-6078, 11/2018, Volume 103, Issue 12, pp. e590 - e593
Journal Article
Leukemia, ISSN 0887-6924, 08/2019
We report assessment of minimal residual disease (MRD) status and its association with outcome in rituximab-refractory follicular lymphoma (FL) in the... 
Journal Article
ONCOLOGY (United States), ISSN 0890-9091, 04/2014, Volume 28, Issue 4, pp. 334 - 336
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.